Phase II Feasibility study of Weekly Amrubicin in Patients with Previously Treated Non-small Cell Lung Cancer
Phase 2
Recruiting
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000009340
- Lead Sponsor
- Tsuchiura Kyodo General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients with active severe infections (2) Patients with cardiac infarction or necessary cardiac function abnormality of the treatment (3) Patients with active interstitial pneumonia recognized by chest X-ray or chest CT (4) Received the maximum allowed cumulative dose of cardiotoxic drugs such as anthracycline derivatives in prior therapy (5) Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events
- Secondary Outcome Measures
Name Time Method Disease control rate Progression-free survival Overall survival